PRAH
PRA Health Sciences Inc
Price:  
165.21 
USD
Volume:  
2,452,670.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRAH EV/EBITDA

-39.5%
Upside

As of 2024-03-01, the EV/EBITDA ratio of PRA Health Sciences Inc (PRAH) is 25.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRAH's latest enterprise value is 11,283.55 mil USD. PRAH's TTM EBITDA according to its financial statements is 435.00 mil USD. Dividing these 2 quantities gives us the above PRAH EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.4x - 16.8x 16.2x
Forward P/E multiples 14.5x - 18.4x 16.2x
Fair Price 87.88 - 115.61 99.93
Upside -46.8% - -30.0% -39.5%
165.21 USD
Stock Price
99.93 USD
Fair Price

PRAH EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA